Literature DB >> 25832880

'Liver-first' approach for metastatic colorectal cancer.

Marcello Donati1, Gregor A Stavrou, Axel Stang, Francesco Basile, Karl J Oldhafer.   

Abstract

The liver-first approach was proposed for the first time in 2006 to obtain resectability of stage IV colorectal cancer patients and complete the therapeutic plan. From then some groups have used this new revolutionary approach reporting promising results. Other alternative strategies have been proposed for metastatic patients. The authors reviewed the literature weighing the pros and cons of each strategy proposed to manage these advanced tumor stages. The therapeutic options are analyzed in the light of oncologic problems and evidence. Also problems, questions and perspectives are given. Even if the 'liver-first' approach seems to be a promising strategy, the ideal diagnostic-therapeutic flowchart for metastatic colorectal cancer is still difficult to standardize. The great heterogeneity of this population of patients is one of the main problems. A 'tailored approach' philosophy is necessary to calibrate, in a multidisciplinary setting, a case-by-case choice of therapeutic options.

Entities:  

Keywords:  colorectal liver metastasis; liver-first; metastatic cancer; multidisciplinary tumor board; neoadjuvant chemotherapy; rectal cancer

Mesh:

Year:  2015        PMID: 25832880     DOI: 10.2217/fon.14.316

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  2 in total

Review 1.  Perspectives for circulating tumor DNA in clinical management of colorectal cancer.

Authors:  Ichiro Takemasa; Atsushi Hamabe; Masayuki Ishii
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

2.  Complete pathological response of post neoadjuvant chemotherapy in colorectal cancer with liver metastasis: a case report.

Authors:  Ragad I Al Jazzar; Mohammed Algarni; Sarah Al-Maiman; Nayef Alzahrani
Journal:  J Surg Case Rep       Date:  2022-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.